Navigation Links
Abaxis Announces New Waived Kidney Check Panel Exclusively for Imaging and Radiology Centers
Date:10/3/2007

UNION CITY, Calif., Oct. 3 /PRNewswire-FirstCall/ -- Abaxis, Inc. (Nasdaq: ABAX), a medical products company manufacturing point-of-care blood chemistry analysis systems, announced today the launch of the Kidney Check Panel to be used in conjunction with the Piccolo xpress(TM) point of care analyzer.

The new Kidney Check Panel was designed specifically for imaging and radiology centers in the United States to determine the level of renal insufficiency prior to the injection of contrast agents for MRI procedures. This panel contains Creatinine (CRE) and Urea Nitrogen (BUN). As a result of prior FDA clearance on these two analytes, the Kidney Check Panel is released as a CLIA-waived panel.

"Many contrast mediums currently used during an MRI procedure in the outpatient setting can have an adverse effect on the kidneys. The ability to check kidney function prior to and in some cases post MRI, enables the radiologist to rapidly assess the risk level of each patient. In recent months, the FDA has released black box warnings on some of these gadolinium-based contrast agents," stated Dr. Dennis Bleile, Director of Assay Performance and Compliance for Abaxis, Inc.

"The Kidney Check Panel provides a critical solution for the rapid, on-site classification and triaging of MRI patients," commented Rick Betts, Abaxis' Director of Marketing. "We believe this latest CLIA-waived offering answers a significant need for the imaging and radiology market by providing a simple, fast and accurate chemistry solution for on-site kidney function analysis. We also believe the Kidney Check Panel will help increase the efficiency and reduce the risks for our imaging and radiology center customers."

About Abaxis, Inc.

Abaxis develops, manufactures and markets portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements. The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients. The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples. The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer. The veterinary business also provides to the veterinarian and research market a line of hematology instruments for point of care complete blood counts (CBC).

This press release includes statements that constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Abaxis claims the protection of the safe-harbor for forward-looking statements contained in the Reform Act. Specific forward-looking statements contained in this press release include, but are not limited to, risks and uncertainties related to the market acceptance of the Company's products and the continuing development of its products, risks associated with manufacturing and distributing its products on a commercial scale, risks associated with entering the human diagnostic market on a larger scale, risks involved in carrying of inventory, risks from unexpected problems or delays in the Company's manufacturing facility, risks associated with the ability to attract and retain competent sales personnel, general market conditions, competition, risks and uncertainties related to its ability to raise capital in order to fund its operations and other risks detailed from time to time in Abaxis' periodic reports filed with the United States Securities and Exchange Commission. Forward-looking statements speak only as of the date the statement was made. Abaxis does not undertake and specifically disclaims any obligation to update any forward-looking statements.

Contact: Clint Severson Lytham Partners, LLC

Chief Executive Officer Joe Dorame, Joe Diaz & Robert Blum

Abaxis, Inc. 602-889-9700

510-675-6500


'/>"/>
SOURCE Abaxis, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. PM announces a new health care order for India
2. Ramdoss Announces Introduction of RCH-II
3. Britain Announces Third Transfusion Related Mad Cow Case
4. Gates Foundation Announces $287 Million In Grants Towards AIDS Vaccine
5. Tibet Announces the Dalai Lama’s Tour of South Americ
6. NHS announces further Cost cutting Measures
7. Indian PM Announces Of Setting Up India Study Center At Tashkent
8. PowderMed Announces Needle-Less Flu Vaccine
9. Malaysia Announces Prison term On People Donating HIV-Contaminated Blood
10. Australian Government Announces Survey To Tackle Childhood Obesity
11. New Zealand Announces 10-year Plan For Betterment Of Mental Health Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/24/2017)... Providenciales, Turks & Caicos Islands, BWI (PRWEB) , ... September 24, ... ... Caicos Islands, the #1 rated resort on TripAdvisor and one of Provo's premier boutique ... was no reported structural damage to the resort after devastating Hurricanes Irma and more ...
(Date:9/24/2017)... ... ... I”, a young boy was walking home and feeling down about himself. He didn’t think ... new friend says he can do whatever he wants to do if he puts his mind ... he is. God created him with special talents and gifts. We see his internal dialogue ...
(Date:9/23/2017)... ... September 23, 2017 , ... ... to fighting obesity of Robert Kushner, director of Chicago’s Center for Lifestyle Medicine ... promoting healthier habits, the article notes that the center routinely recommends weight loss ...
(Date:9/22/2017)... ... 2017 , ... MEDIA OPPORTUNITY: , Save Our Hospital - Albert Lea will ... are rallying against Mayo Clinic. Specifically, media can talk to steering committee members and ... to close the Albert Lea hospital. , The rally aims to protect the most ...
(Date:9/22/2017)... ... 2017 , ... Fenwick Agency of Plano, TX has announced the commencement of ... the nationally recognized ‘Agents of Change’ movement. The agency pledges to select a new ... seek out those who most need help. Their hope is to bring awareness to ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... -- Robert G. Szewc, M.D., is recognized by Continental Who,s ... his contributions to the Medical field.      ... practice of Kidney and Hypertension Specialists, which specializes in ... He has worked in this position since 2002, and ... as expertise in kidneys, hypertension, chronic disease and anemia, ...
(Date:9/6/2017)...   PDI , a leader in infection prevention ... educational session focused on the role of chlorhexidine gluconate ... the 2017 Annual Scientific Meeting of the Association for ... the Phoenix Convention Center in ... will also feature PDI,s Prevantics® Device Swab ...
(Date:9/6/2017)... Sept. 6, 2017 Eli Lilly and Company ... present new data for galcanezumab and lasmiditan, two investigational ... International Headache Society (IHC) taking place Sept. 7-10 in ... will highlight new, long-term data from an open-label study ... galcanezumab (120 mg and 240 mg) for the prevention ...
Breaking Medicine Technology: